Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$1.68B |
 |
MedtronicMDT |
-$87M |
 |
Edwards LifesciencesEW |
-$288M |
 |
Intuitive SurgicalISRG |
-$1.2B |
 |
ConmedCNMD |
-$2.6M |
Are Vivos Therapeutics Insiders Buying or Selling?
Vivos Therapeutics (VVOS) has had no reported insider transactions in the past 90 days. The most recent was Michael Skaff, who bought 2,749,330 shares at $0.58 on June 30, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the VVOS AI Score. For government officials trading this stock, see VVOS congressional trading.
Who’s Trading Vivos Therapeutics Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Michael Skaff | Bought $8M | 7 | Jun 30, 2026 |
Recent Vivos Therapeutics Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Skaff | Jun 30, 2026 | Buy | 2,749,330 | $0.58 | $1.6M |
| Michael Skaff | Jun 30, 2026 | Buy | 1,890,164 | $0.58 | $1.1M |
| Michael Skaff | Jun 30, 2026 | Buy | 859,166 | $0.58 | $500,000 |
| Michael Skaff | Mar 31, 2026 | Buy | 1,783,582 | $1.34 | $2.4M |
| Michael Skaff | Mar 31, 2026 | Buy | 1,044,777 | $1.34 | $1.4M |
| Michael Skaff | Mar 31, 2026 | Buy | 429,957 | $1.34 | $580,000 |
| Michael Skaff | Mar 31, 2026 | Buy | 308,848 | $1.34 | $410,000 |
Frequently Asked Questions: Vivos Therapeutics Insider Trading
Vivos Therapeutics insiders have not reported any transactions in the past 90 days.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Skaff Michael C has bought the most VVOS stock in the last 2 years, with a total value of $8M.
According to our estimates, the total value of insider transactions for Vivos Therapeutics in the last 2 years is positive, amounting to $8M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
